tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:APLI Stock Latest News

Appili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
Company AnnouncementsAppili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
8d ago
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
PremiumCompany Announcements
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
14d ago
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
PremiumCompany Announcements
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
2M ago
Appili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
PremiumCompany Announcements
Appili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
3M ago
Appili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
PremiumCompany Announcements
Appili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
4M ago
Appili Therapeutics prices 30M units at $0.025 in private placement
PremiumThe FlyAppili Therapeutics prices 30M units at $0.025 in private placement
4M ago
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
Premium
Company Announcements
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
4M ago
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
Premium
Company Announcements
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
5M ago
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
PremiumThe Fly
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
5M ago
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
PremiumCompany Announcements
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
5M ago
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
PremiumCompany Announcements
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
6M ago
Appili Therapeutics to present progress on Tularemia vaccine
PremiumThe Fly
Appili Therapeutics to present progress on Tularemia vaccine
6M ago
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
PremiumCompany AnnouncementsAppili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
7M ago
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
Premium
The Fly
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
7M ago
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
Premium
Company Announcements
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
7M ago
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
PremiumCompany Announcements
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
8M ago
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
PremiumCompany Announcements
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
9M ago
Appili Therapeutics Faces Termination of Agreement with Aditxt
PremiumCompany Announcements
Appili Therapeutics Faces Termination of Agreement with Aditxt
9M ago
Aditxt announces termination of arrangement agreement with Appili Therapeutics
PremiumThe Fly
Aditxt announces termination of arrangement agreement with Appili Therapeutics
9M ago
ADTX
Appili Therapeutics Advances Tularemia Vaccine Research
PremiumCompany AnnouncementsAppili Therapeutics Advances Tularemia Vaccine Research
10M ago
Appili Therapeutics publishes manuscript on emergency response to tularemia
Premium
The Fly
Appili Therapeutics publishes manuscript on emergency response to tularemia
10M ago
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
Premium
Company Announcements
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >